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ABSTRACT
Coronary artery perforation (CAP) after percutaneous coronary intervention is a rare, but serious complication. It can cause 
cardiac tamponade, acute myocardial infarction or death. The treatments of CAP involve prolonged balloon inflation, emer-
gent surgery, coil embolization, and implantation of covered stent. We have successfully performed the emergent microcoil 
embolization in a patient with uncontrolled Ellis grade 3 guidewire-induced CAP resulting in delayed cardiac tamponade.  
Contrasting our usual expectation, the 1-year follow-up angiography showed a patent flow at the embolized site. (Korean 
Circ J 2011;41:474-478)
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Introduction
Coronary artery perforation (CAP) which occurs either 
during or following percutaneuous coronary intervention 
(PCI) is an infrequent complication, but one of the most di-
sastrous complications of this cardiovascular surgery proce-
dure.
1-9) It has been related to vessel wall penetration with 
guidewire, balloon overexpansion or rupture, atheroablative 
techniques, and stent implantation. Various management te-
chniques have been successful. Some reports have shown that 
helical platinum microcoil embolization was used for CAP.
10-15) 
Contrasting the usual expectation that an embolized artery 
will not show any blood flow, this report shows preserved 
normal blood flow at the embolization site on the 1 year fol-
low-up angiography, following emergent lifesaving microcoil 
embolization, in a patient with uncontrolled Ellis grade 3 
guidewire-induced CAP, resulting in cardiac tamponade. In 
the literature, there are no other similar case reports from a 
follow-up angiography after microcoil embolization, especial-
ly in a case such as the one presented herein, where the flow 
was maintained at the embolized site.
Case
A 51-year-old male patient with a 30 pack-year current 
smoking presented with a recent onset of exertion chest pain. 
He had a free medical history. The treadmill test provoked se-
vere chest pain, without ST changes on the electrocardiogra-
phy (ECG), at stage 2 of the modified Bruce protocol. The pa-
tient underwent elective coronary angiography via the left 
femoral approach, which revealed a discrete critical narrow-
ing of the middle left anterior descending artery (LAD), just 
distal to the first diagonal branch (D1) (Fig. 1A). A 7 Fr JL4 gu-
ide catheter (Cordis, Miami, FL, USA) was used to engage the 
left main coronary artery, and a 0.014” ATW
TM guidewire (Cor-
dis, Miami, FL, USA) was passed into the distal LAD, without 
difficulty. The proposed treatment was a cross-over stenting 
followed by provisional T stenting at that lesion site. Angio-
plasty was performed twice with the Ryujin
TM Plus (TERUMO, 
Tokyo, Japan) 3.5×10 mm balloon at 6-atm (up to 3.5 mm) in-Jae Hyun Kim, et al.   475
flation. A Zotarolimus-Eluting stent (Endeavor Resolute, Med-
tronic, Minneapolis, MN, USA) 4.0×15 mm stent was deploy-
ed, with 12-atm (up to 4.08 mm) inflation. The repeat angio-
gram showed adequate deployment of the stent, but a jailed D1 
(Fig. 1B). An attempt was made to pass into D1 using a 0.014” 
Choice
TMPT guidewire (Boston Scientific, Miami, FL, USA) 
through the in-stent. After initially inflating a Sprinter (Med-
tronic, Minneapolis, MN, USA) 3.0×15 mm semi-compliant 
balloon, up to 3.18 mm at the D1 ostium, ‘kissing’ balloon an-
gioplasty, using a Sprinter 3.5×15 mm for the LAD and a Sp-
rinter 3.0×15 mm for D1, was finally performed (Fig. 1C). 
The final angiographic result appeared good, without any com-
plications (Fig. 1D). During observation in the intensive care 
unit, the patient grumbled about some chest tightness, but was 
hemodynamically stable. Three hours after PCI, he com-
plained of more severe chest pain, dyspnea, tachypnea and 
heavy sweating. Moreover, his systolic blood pressure dropped 
to below 60 mmHg. An emergent echocardiogram was taken 
at the patient’s bedside, under the suspicion of a cardiac tam-
ponade, due to delayed extravasation after PCI. It showed a 
pericardial effusion of less than 10 mm, as well as the collapse 
of the right atrium. Emergency pericardiocentesis was per-
formed and over 100 mL of bloody pericardial fluid was ini-
tially drained. The patient’s vital signs returned to normal. Pe-
ricardial fluids were drained continuously and blood was 
transfused through the peripheral vein, with the expectation 
that it will stop the extravasation spontaneously. Considering 
the drainage rate of the pericardial fluid at over 200 mL/hr, a 
large perforation of the coronary artery at the stenting site was 
suspected. However, an emergent angiogram showed massive 
extravasation (Ellis Grade 3 coronary perforation) at the far dis-
tal area of D1 (Fig. 2A). An attempt was made to re-cross D1 
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Fig. 1. Angiograms obtained during percutaneous coronary intervention. A: AP cranial view of the left anterior descending artery (LAD), 
showing a severe stenosis (black arrow) at the middle portion, just distal to the first diagonal branch (D1). B: view after 4.0×15 mm Zotaroli-
mus-eluting stent was inserted at the middle LAD, showing a tight narrowing (white arrow) at the ostium of D1. C: kissing balloon angio-
plasty for LAD with a 3.5×15 mm Sprinter semi-compliant balloon and a 3.0×15 mm Sprinter balloon for D1. D: final angiogram.476   A Case of Reestablishment of the Flow at the Microcoil Embolization Site
and a Sprinter 3.0×15 mm semi-compliant coronary balloon 
with low pressure was inflated at the middle portion of D1. 
However, the perforation could not be sealed and continuous 
leakage occurred after the balloon’s deflation, even after an 
inflation period of over 60 minutes. We attempted to occlude 
the D1 branch via a microcoil embolization to repair the per-
foration site completely. A MicroFerret
® superselective cathe-
ter (Cook, Sandet, Denmark) was advanced superselectively 
into D1 at the level of the perforation. One 0.018-inch and 
14.2-mm-long tapered microcoil (10×4 mm in diameter; Tor-
nado; Cook, Bloomington, IN, USA) was quickly released, 
using the microcatheter’s supporting guidewire (Transend
® 
300, Boston Scientific, Miami, FL, USA) as a pusher. A post-
coil LAD arteriogram demonstrated the total occlusion of 
D1 and no further extravasation (Fig. 2B). On the following 
day, the post procedure echocardiogram revealed an ejection 
fraction of 60%, with mild hypokinesia on the apical lateral 
and apical anterior walls, and no pericardial effusion. The peak 
infarct size, as measured using serum biomarkers, was a tro-
ponin of 2.65 ng/mL and a creatinine phosphokinase-MB of 
100.8 ng/mL. The patient was uneventful and discharged 5 
days later in a stable condition. Three months after the PCI, 
he took the treadmill test and the echocardiogram. The tr-
eadmill test provoked chest pain at stage 5, with a 1 mm ST de-
pression on the ECG, and the echocardiogram showed no 
interval change. For 12 months after PCI, the patient had sev-
eral episodes of chest pain and dyspnea on exertion. He then 
underwent repeated coronary angiography. Angiographic 
findings of D1 showed a normal flow without delay (Fig. 2C). 
The treadmill test showed a negative finding. 
Discussion
CAP may range clinically from guidewire-related microper-
forations, resulting in minimal dye staining without haemo-
dynamic consequences, to vessel rupture followed by active 
extravasations of blood and dye into the pericardial space, 
leading to tamponade and sudden haemodynamic collapse. 
It has been reported at variable rates, depending on the pro-
cedures performed, lesions treated and devices used. In the 
recent registries, perforation has been reported to occur in 
0.17-1.5% of all patients undergoing PCI.
9)16-18) The incid-
ence of these complications has been increased by the use of 
debulking devices, such as high-speed rotational atherecto-
my and directional coronary atherectomy.
2)3)5-7)17) Guidewire-
induced perforation seems to be the most frequent cause of 
CAP-accounting for 20 to 68% of CAP incidents.
2)3)5-9)16-18) In 
PCI of complex lesions, including chronic total occlusions and 
bifurcation lesions, the use of both hydrophilic and heavy-
weight guidewires has also increased the frequency of this 
complication.
2)4)7)9)17) A Choice
TMPT wire was used for cross-
ing the D1 branch in this case. We suspected that the hydro-
philic guidewire-induced damage occurred with the attempt 
to treat the jailed branch, using the ‘kissing’ balloon techni-
que. This Choice
TMPT wire was coated with a highly lubrici-
ous hydrogel and was moderately stiff, compared with the new-
generation guidewires. Due to this low coefficient of friction 
and easy distal migration,
10)11)15)19) caution should be exercis-
ed in positioning the tip of the guidewire distally.
After the perforation diagnosis, treatment strategy varies, 
according to the clinical situation, i.e., the size of the perfo-
ration, the extent of contrast extravasation, and the hemodyna-
mic status of the patients. The initial management involves 
the inflation of an angioplasty balloon proximal to or at the 
level of the perforation to seal the leak, and pericardioentesis 
can be performed if cardiac tamponade is present. Depend-
ing on the bleeding control, complete management modali-
ties should be considered-from surgery to less invasive per-
Fig. 2. An emergent and 1-year follow-up coronary angiogram. A: coronary artery perforation, evidenced by contrast leak into the pericardi-
um from the distal end of the diagonal branch (D1) of left anterior descending artery (area marked by white triangles). B: embolization of D1 
by helical microcoil (white arrow), with no evidence of contrast leak. C: showing surprising patent flow at the embolized site of D1 on the fol-
low-up angiogram.
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cutaneous techniques: covered stents/grafts or thrombus in-
ducing therapies, such as polyvinyl alcohol, autologous blood 
or intracoronary bead injection. If a cardiac surgeon were 
unavailable, one might have to choose another option for con-
trolling the patient’s bleeding. Because a covered stent is 
bulky, has a large diameter (of over 3 mm), and is not easy to 
pass through the side hole of a stent in the parent artery, this 
device could not be used with the continuous bleeding from 
the perforation in this case. In the event that the perforation 
is in a small sized branch, the operator may consider exclud-
ing the whole branch by coiling, bead seeding, or implanting 
other thrombogenic agents directly into the branch. The use 
of the microcoil was very effective in the patient presented 
herein. In recent studies, the prevalence of microcoil emboliz-
ation as a treatment option of CAP was 0.1-4%.
1)8)17) It is not 
common but it may play an important role when traditional 
management for CAP has failed.
Microcoils have been used as permanent embolic agents 
for occlusion of cerebral aneurysms, gastrointestinal hemor-
rhage, and other peripheral vascular therapeutic maneuvers. 
They offer the advantage of precise placement into very distal 
locations. However, due to the permanent loss of the vessel 
lumen beyond the site of the microcoil placement and the sub-
sequent infarction, their use in the coronary arteries should 
be limited to distal small-vessel perforation in life-threaten-
ing circumstances, in which no other options are readily avail-
able. The Tornade
® embolization microcoils (Cook) have a 
soft platinum structure with synthetic fibers that maximize 
thrombogenicity. Moreover, their helical configuration max-
imizes the coil exposure to the cross-section of the lumen for 
the disruption of the flow. To allow proper adherence to the 
vessel wall, the coil size should be slightly (25%) larger than 
the target vessel diameter. This case describes the successful 
management of CAP, with the sacrifice of the D1 via coil em-
bolization. Nevertheless, at the follow-up angiography, a patent 
blood flow was evident at the site where the microcoil was 
inserted. This case, therefore, is not only the first angiographic 
result of microcoil embolization presented to date, but also, 
particularly, the first example of maintenance of the blood 
flow at the embolized site, which was against our expecta-
tions of complete occlusion. Why did this happen? The best 
hypothesis is that, although a very large microcoil was insert-
ed, initially inducing a thrombus, this thrombosis state could 
not be maintained due to inadequate adherence to the vessel 
under dual antiplatelet therapy. 
The patient developed cardiac tamponade 3 hours after 
PCI. Although some perforations are quite evident in the ca-
theterization laboratory, others remain initially occult, only 
to become clinically apparent hours after the procedure. Car-
diac tamponade complications occur in 11-46% of patients 
experiencing CAP after PCI.
1-4)7-9)16)17) Delayed tamponade 
comprised 20-60% of these tamponade complications,
3)4)20) 
and was common in the perforations (e.g., ELLIS type I) in-
duced by either guidewire or glycoprotein IIb/IIIa inhibitor 
use.
16)20) Thus, this diagnosis should remain high on the list 
of differential diagnoses of post-PCI hypotension. In these 
cases, the diagnosis of CAP should be ruled out, especially if 
retroperitoneal bleeding is not present. Close observation is 
strongly advised in all PCI cases because, if not recognized, 
bleeding from CAP can rapidly lead to death from cardiac 
tamponade. 
CAP is a rare, but disastrous complication of PCI. In select-
ed cases of distal coronary perforations, microcoil emboliza-
tion may be a reasonable alternative therapeutic approach. 
However, an obvious drawback of this approach is the per-
manent loss of the vessel lumen beyond the site of the mi-
crocoil placement and the subsequent infarction. Therefore, 
this approach should be limited either to life-threatening cir-
cumstances, in which no other options are readily available, 
or to the treatment of very distal perforations, where the am-
ount of myocardium that is jeopardized is minimal. Despite 
a large, hemodynamically significant perforation, the suc-
cessful management of CAP with the sacrifice of the D1 via 
coil embolization is described in this case. A notable, unex-
pected result was evident at the patient’s follow-up one-year 
angiography, i.e., a patent blood flow existed at the site where 
the microcoil was inserted.
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